Cargando…
Interleukin-1 mediates Alzheimer and Lewy body pathologies
BACKGROUND: Clinical and neuropathological overlap between Alzheimer's (AD) and Parkinson's disease (PD) is now well recognized. Such cases of concurrent AD and Lewy body disease (AD/LBD) show neuropathological changes that include Lewy bodies (α-synuclein aggregates), neuritic amyloid pla...
Autores principales: | Griffin, W Sue T, Liu, Ling, Li, Yuekui, Mrak, Robert E, Barger, Steven W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1435743/ https://www.ncbi.nlm.nih.gov/pubmed/16542445 http://dx.doi.org/10.1186/1742-2094-3-5 |
Ejemplares similares
-
Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer’s disease
por: Mrak, Robert E, et al.
Publicado: (2007) -
Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors
por: Liu, Ling, et al.
Publicado: (2011) -
Interleukin-1β drives NEDD8 nuclear-to-cytoplasmic translocation, fostering parkin activation via NEDD8 binding to the P-ubiquitin activating site
por: Balasubramaniam, Meenakshisundaram, et al.
Publicado: (2019) -
EEG Characteristics of Dementia With Lewy Bodies, Alzheimer’s Disease and Mixed Pathology
por: van der Zande, Jessica J., et al.
Publicado: (2018) -
Plasma sphingolipid changes with autopsy-confirmed Lewy body or Alzheimer's pathology
por: Savica, Rodolfo, et al.
Publicado: (2016)